These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 33047841

  • 1. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
    Wei Q, Jiang Y, Xie J, Lv Q, Xie Y, Tu L, Xiao M, Wu Z, Gu J.
    J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
    [Abstract] [Full Text] [Related]

  • 2. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
    Wei Q, Jiang Y, Xie J, Yang M, Zhang Y, Wu Z, Chen S, Liao Z, Lin Z, Gu J.
    Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD).
    Seelig CA, Bauer O, Seelig HP.
    Clin Lab; 2016 Aug; 62(4):499-517. PubMed ID: 27215068
    [Abstract] [Full Text] [Related]

  • 4. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.
    Peker BO, Şener AG, Tarhan EF, Kaya S.
    Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837
    [Abstract] [Full Text] [Related]

  • 5. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC, Sapkota S, Peterson DJ, Crosson JT.
    J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
    [Abstract] [Full Text] [Related]

  • 6. Distinctive features of positive anti-cell antibody tests (indirect immunofluorescence on HEp-2 cells) in patients with non-autoimmune diseases.
    Agustinelli RA, Rodrigues SH, Mariz HA, Prado MS, Andrade LEC.
    Lupus; 2019 Apr; 28(5):629-634. PubMed ID: 31027463
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A, Çetin Duran A, Taşkıran İ.
    Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of screening enzyme immunoassays compared to indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Jeong S, Yang D, Lee W, Kim GT, Kim HS, Ahn HS, Kim HJ.
    Semin Arthritis Rheum; 2018 Oct; 48(2):334-342. PubMed ID: 29609799
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z, Ren Y, Liu D, Lin F, Liang Y.
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [Abstract] [Full Text] [Related]

  • 10. Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
    Irure-Ventura J, Rodríguez C, Vergara-Prieto E, Vargas ML, Quirant B, Jurado A, Fernández-Pereira L, Martínez-Cáceres E, San José M, López-Hoyos M, GEAI and EASI groups.
    Rheumatology (Oxford); 2021 Aug 02; 60(8):3904-3912. PubMed ID: 33437990
    [Abstract] [Full Text] [Related]

  • 11. Range of antinuclear antibodies in "healthy" individuals.
    Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA.
    Arthritis Rheum; 1997 Sep 02; 40(9):1601-11. PubMed ID: 9324014
    [Abstract] [Full Text] [Related]

  • 12. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.
    Ann Rheum Dis; 2004 Oct 02; 63(10):1250-4. PubMed ID: 15361381
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
    Frodlund M, Wetterö J, Dahle C, Dahlström Ö, Skogh T, Rönnelid J, Sjöwall C.
    Clin Exp Immunol; 2020 Mar 02; 199(3):245-254. PubMed ID: 31778219
    [Abstract] [Full Text] [Related]

  • 14. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M, Parker T, Peebles CL, Andrade LE, Swart A, Carbone Y, Ferguson DJ, Villalta D, Bizzaro N, Hanly JG, Fritzler MJ.
    J Rheumatol; 2012 Nov 02; 39(11):2104-10. PubMed ID: 22942262
    [Abstract] [Full Text] [Related]

  • 15. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
    Yumuk Z, Demir M.
    J Immunol Methods; 2020 May 02; 480():112754. PubMed ID: 32057435
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
    González Rodríguez C, Fuentes Cantero S, Pérez Pérez A, Vázquez Barbero FJ, León Justel A.
    J Clin Lab Anal; 2021 Sep 02; 35(9):e23914. PubMed ID: 34347308
    [Abstract] [Full Text] [Related]

  • 17. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J, Grossmann K, Knütter I, Hiemann R, Sowa M, Röber N, Rödiger S, Schierack P, Reinhold D, Bogdanos DP, Meroni PL, Radice A, Conrad K, Roggenbuck D.
    Clin Chem Lab Med; 2015 Nov 02; 53(12):1991-2002. PubMed ID: 26020561
    [Abstract] [Full Text] [Related]

  • 18. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
    Baglaenko Y, Chang NH, Johnson SR, Hafiz W, Manion K, Ferri D, Noamani B, Bonilla D, Rusta-Sellehy S, Lisnevskaia L, Silverman E, Bookman A, Landolt-Marticorena C, Wither J.
    Arthritis Res Ther; 2018 Nov 29; 20(1):264. PubMed ID: 30486869
    [Abstract] [Full Text] [Related]

  • 19. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P, Barrile A, Bonanno D, Giannetto L, Patafi M, Tigano V, Ferlazzo B.
    Reumatismo; 2005 Nov 29; 57(2):109-13. PubMed ID: 15983634
    [Abstract] [Full Text] [Related]

  • 20. A novel magnetic bead-based immunoprecipitation method for anti-dense fine speckled 70 antibodies.
    Chen R, Wei X, Yang C, Nguyen K.
    Pathology; 2023 Oct 29; 55(6):843-849. PubMed ID: 37336684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.